Literature DB >> 16167080

Epidemiology of pterygium on a tropical island in the Riau Archipelago.

C S H Tan1, T H Lim, W P Koh, G C Liew, S T Hoh, C C Tan, K G Au Eong.   

Abstract

OBJECTIVES: To describe the epidemiology of pterygium among residents of an island in Indonesia and to examine the roles of age and gender as determinants of bilaterality and severity of the disease.
METHODS: Voluntary eye screening on Pulau Jaloh, Riau Archipelago, Indonesia. Gender difference was tested using the chi2 test. The difference in age between subjects with and without disease was tested using unpaired Student's t-test. Odds ratio (relative risk) for gender was calculated using logistic regression model with adjustment for age.
RESULTS: Of the 550 inhabitants, 477 (86.7%) responded to the eye screening. The overall prevalence rate of pterygium was 17.0%. Out of 211, 48 male (22.7%) and 33 out of 266 female subjects (12.4%) had the disorder, with the gender difference being statistically significant. Adjusted for age, the risk of disease was 3.1-fold higher among the males. In all, 71.6% of subjects with pterygium had bilateral disease. Subjects with pterygium were significantly older, their mean age being 42.9 years compared to 18.7 years among those without disease. The prevalence rates in male subjects increased from age 20 to reach a plateau of 63.6% at age 35 and remained stable thereafter. In the female subjects, the rates also increased with age, albeit at a slower rate, from age 20 to reach a plateau of 46.7% at age 55 and remained stable thereafter.
CONCLUSIONS: There is a high prevalence rate of pterygium among the study subjects, with the rates increasing rapidly with age.

Entities:  

Mesh:

Year:  2005        PMID: 16167080     DOI: 10.1038/sj.eye.6702046

Source DB:  PubMed          Journal:  Eye (Lond)        ISSN: 0950-222X            Impact factor:   3.775


  19 in total

1.  Prevalence of pinguecula and pterygium in a general population in Spain.

Authors:  E Viso; F Gude; M T Rodríguez-Ares
Journal:  Eye (Lond)       Date:  2010-12-24       Impact factor: 3.775

2.  Pterygium.

Authors:  A S Solomon
Journal:  Br J Ophthalmol       Date:  2006-06       Impact factor: 4.638

3.  Ophthalmic pterygium: a stem cell disorder with premalignant features.

Authors:  Jeanie Chui; Minas T Coroneo; Lien T Tat; Roger Crouch; Denis Wakefield; Nick Di Girolamo
Journal:  Am J Pathol       Date:  2011-02       Impact factor: 4.307

4.  Prevalence and racial differences in pterygium: a cross-sectional study in Han and Uygur adults in Xinjiang, China.

Authors:  Ting Chen; Lin Ding; Guangliang Shan; Limujiang Ke; Jin Ma; Yong Zhong
Journal:  Invest Ophthalmol Vis Sci       Date:  2015-01-27       Impact factor: 4.799

5.  Risk Factors for Pterygium in Ilam Province, Iran.

Authors:  Parviz Malekifar; Hamed Esfandiari; Nazanin Behnaz; Fatemeh Javadi; Sima Azish; Mohammad Ali Javadi; Masumeh Kalantarion
Journal:  J Ophthalmic Vis Res       Date:  2017 Jul-Sep

Review 6.  Pterygium: an update on pathophysiology, clinical features, and management.

Authors:  Toktam Shahraki; Amir Arabi; Sepehr Feizi
Journal:  Ther Adv Ophthalmol       Date:  2021-05-31

7.  Inhibition by female sex hormones of collagen degradation by corneal fibroblasts.

Authors:  Hongyan Zhou; Kazuhiro Kimura; Tomoko Orita; Teruo Nishida; Koh-Hei Sonoda
Journal:  Mol Vis       Date:  2011-12-27       Impact factor: 2.367

8.  The prevalence of pterygium in Alkhobar: A hospital-based study.

Authors:  Jerman M Alqahtani
Journal:  J Family Community Med       Date:  2013-09

9.  Geographical prevalence and risk factors for pterygium: a systematic review and meta-analysis.

Authors:  Lei Liu; Jingyang Wu; Jin Geng; Zhe Yuan; Desheng Huang
Journal:  BMJ Open       Date:  2013-11-19       Impact factor: 2.692

10.  Associations between arsenic in drinking water and pterygium in southwestern Taiwan.

Authors:  Wei Lin; Shu-Li Wang; Horng-Jiun Wu; Kuang-Hsi Chang; Peter Yeh; Chien-Jen Chen; How-Ran Guo
Journal:  Environ Health Perspect       Date:  2008-07       Impact factor: 9.031

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.